Eterna Therapeutics

🇺🇸United States
Ownership
-
Employees
8
Market Cap
$9.6M
Website
Introduction

Eterna Therapeutics, Inc. engages in the provision of cell engineering therapies. It is involved in the development of mRNA cell engineering technologies to repair cellular dysfunction and treat a range of therapeutic indications. The company was founded in 1984 and is headquartered in Cambridge, MA.

© Copyright 2024. All Rights Reserved by MedPath